Affymetrix Reschedules the Issuance of Third Quarter 2012 Operating Results & Conference Call to Monday November 5th, 2012 Du...
31 October 2012 - 7:00AM
Business Wire
Affymetrix, Inc. (NASDAQ: AFFX) today announced that the company
has rescheduled the issuance of third quarter 2012 operating
results and the associated conference call to after market close on
Monday November 5th, 2012.
Affymetrix’s management team will host a conference call on
Monday November 5, 2012 at 2:00 p.m. PT. A live webcast can be
accessed by visiting the Investor Relations section of the
Company's website at www.affymetrix.com. In addition, investors and
other interested parties can listen by dialing domestic: (877)
407-4812, international: (201) 689-8345.
A replay of this call will be available from 5:00pm PT on
November 5, 2012 until 8:00pm PT on November 12, 2012 at the
following numbers: 877-660-6853 (domestic), 201-612-7415
(international). The passcode to access the conference call is
401334. An archived webcast of the conference call will be
available under the investor relations section of the company's
website at www.affymetrix.com.
About Affymetrix
Affymetrix technology is used by the world's top pharmaceutical,
diagnostic, and biotechnology companies, as well as leading
academic, government, and nonprofit research institutes. More than
2,000 systems have been shipped globally and approximately 25,000
peer-reviewed papers have been published using the technology.
Affymetrix is headquartered in Santa Clara, Calif., and has
manufacturing facilities in Santa Clara, Cleveland, San Diego,
Vienna, Austria and Singapore. The company has about 900 employees
worldwide and maintains sales and distribution operations across
Europe, Asia, and Latin America. For more information about
Affymetrix, please visit www.affymetrix.com.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Affymetrix, Inc. (NASDAQ): 0 recent articles
More Affymetrix, Inc. News Articles